-+ 0.00%
-+ 0.00%
-+ 0.00%

Asian Value Stocks Trading At A Discount In August 2026

Simply Wall St·08/25/2026 22:04:31
Listen to the news

As of August 2026, Asian markets have been navigating a complex landscape marked by global economic uncertainties and fluctuating investor sentiment. Despite these challenges, opportunities for value investing persist, with certain stocks trading at a discount offering potential for growth in the long term. Identifying undervalued stocks involves looking for companies with strong fundamentals that remain resilient amid broader market volatility.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Name Current Price Fair Value (Est) Discount (Est)
Winbond Electronics (TWSE:2344) NT$179.00 NT$349.39 48.8%
SILICON2 (KOSDAQ:A257720) ₩51900.00 ₩103326.49 49.8%
Shiyue Daotian Group (SEHK:9676) HK$4.64 HK$9.20 49.6%
Sansha Electric ManufacturingLtd (TSE:6882) ¥1185.00 ¥2339.13 49.3%
Karmarts (SET:KAMART) THB6.80 THB13.39 49.2%
HyVision System (KOSDAQ:A126700) ₩11760.00 ₩22989.17 48.8%
HUMAN MADE (TSE:456A) ¥1721.00 ¥3359.39 48.8%
gremsInc (TSE:3150) ¥2520.00 ¥4910.75 48.7%
CMTXLtd (KOSDAQ:A388210) ₩74000.00 ₩145263.15 49.1%
BEAUTY GARAGE (TSE:3180) ¥1576.00 ¥3106.71 49.3%

Click here to see the full list of 218 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

East Buy Holding (SEHK:1797)

Overview: East Buy Holding Limited is an investment holding company that operates a livestreaming e-commerce business for the sale of private label products in the People's Republic of China, with a market cap of HK$25.19 billion.

Operations: The company generates revenue through its livestreaming e-commerce operations, focusing on the sale of private label products in China.

Estimated Discount To Fair Value: 27.9%

East Buy Holding's recent financial performance demonstrates significant growth, with net income rising to CNY 543.55 million from a mere CNY 5.74 million the previous year. The company is trading at HK$23.92, below its estimated future cash flow value of HK$33.18, suggesting it may be undervalued based on cash flows. Forecasts indicate earnings will grow significantly at 23.51% annually, outpacing the Hong Kong market average of 11.5%.

SEHK:1797 Discounted Cash Flow as at Aug 2026
SEHK:1797 Discounted Cash Flow as at Aug 2026

InSilico Medicine Cayman TopCo (SEHK:3696)

Overview: InSilico Medicine Cayman TopCo focuses on utilizing artificial intelligence solutions for drug discovery and development through its proprietary platforms, with a market capitalization of HK$26.50 billion.

Operations: The company generates revenue of $56.24 million from its biotechnology segment, which involves the application of AI in drug discovery and development.

Estimated Discount To Fair Value: 40.4%

InSilico Medicine Cayman TopCo, trading at HK$46.3, is priced significantly below its estimated future cash flow value of HK$77.71, indicating potential undervaluation based on cash flows. The company is forecasted to achieve 30% annual revenue growth, surpassing the Hong Kong market average of 8.6%. Despite a low projected return on equity of 9.7% in three years, anticipated profitability and strong earnings growth prospects enhance its investment appeal in Asia's biotechnology sector.

SEHK:3696 Discounted Cash Flow as at Aug 2026
SEHK:3696 Discounted Cash Flow as at Aug 2026

EZconn (TWSE:6442)

Overview: EZconn Corporation, along with its subsidiaries, is involved in the assembly, processing, and trading of precision metal parts for electronic components and optical fiber components, with a market cap of approximately NT$124.99 billion.

Operations: Revenue Segments (in millions of NT$):

Estimated Discount To Fair Value: 25.7%

EZconn, priced at NT$1,605, trades 25.7% below its estimated future cash flow value of NT$2,161.37. Recent earnings reports show significant growth with net income reaching TWD 890.42 million in Q2 2026 compared to TWD 195.8 million a year ago. Earnings are projected to grow substantially at over 84% annually, outpacing the Taiwan market's average growth rate and reinforcing its potential as an undervalued stock based on cash flows in Asia.

TWSE:6442 Discounted Cash Flow as at Aug 2026
TWSE:6442 Discounted Cash Flow as at Aug 2026

Make It Happen

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.